Epilepsy :: New indication for Topamax for adults and children with epilepsy
The US Food and Drug Administration (FDA) approved a new use for TOPAMAX (topiramate) Tablets and TOPAMAX (topiramate capsules) Sprinkle Capsules as initial monotherapy in patients 10 years of age and older with partial-onset or primary generalized tonic-clonic seizures.